The Exchange has sought clarification from Medico Remedies Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has asked Medico Remedies Limited to explain why the financial results it submitted for the quarter ended 31 March 2025 were not in the format prescribed by SEBI under Regulation 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015. This relates to how the company reported its quarterly numbers rather than the numbers themselves. The company's response is still pending, and the exchange is awaiting clarification.
This is a procedural compliance issue and not a penalty or action against the company. Shareholders should monitor the company's response, as unresolved clarifications can attract further exchange action, but there is no immediate financial or operational impact on the business.